Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process

Journal of Supercritical Fluids

Volumn 53, Issue 1-3, 2010, Pages 156-164

  Padrela, Luis ^a   Rodrigues, Miguel A ^a   Velaga, Sitaram P ^b   Fernandes, Anabela C ^a   Matos, Henrique A ^a   de Azevedo, Edmundo Gomes ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Crystal engineering; Micronization; Pharmaceutical cocrystals; Solid form screening; Supercritical fluids

Indexed keywords

CO-CRYSTALS; MICRONIZATIONS; SOLID FORM SCREENING; SOLID FORMS;

AMIDES; ATOMIZATION; CRYSTAL ENGINEERING; DIFFERENTIAL SCANNING CALORIMETRY; EFFLUENT TREATMENT; ETHANOL; JETS; POLYMORPHISM; SCANNING ELECTRON MICROSCOPY; STOICHIOMETRY; SUGARS; SUPERCRITICAL FLUIDS; X RAY DIFFRACTION;

DRUG PRODUCTS;

EID: 77951258063     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2010.01.010     Document Type: Article

References (63)

1. Brittain H. Polymorphism in Pharmaceutical Solids (1999), Marcel Dekker, New York
2. Thayer A.M. Form and function. Chem. Eng. News 85 (2007) 17-30
3. Almarsson O., and Zaworotko M.J. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?. Chem. Commun. 17 (2004) 1889-1896
4. Jones W., Motherwell W.D.S., and Trask A.V. Pharmaceutical cocrystals: an emerging approach to physical property enhancement. MRS Bull. 31 (2006) 875-879
5. Vishweshwar P., McMahon J.A., Bis J.A., and Zaworotko M.J. Pharmaceutical co-crystals. J. Pharm. Sci. 95 (2006) 499-516
6. Shan N., and Zaworotko M.J. The role of cocrystals in pharmaceutical science. Drug Disc. Today 13 (2008) 440-446
7. Basavoju S., Boström D., and Velaga S.P. Pharmaceutical cocrystal and salts of norfloxacin. Cryst. Growth Des. 6 (2006) 2699-2708
8. Basavoju S., Bostrom D., and Velaga S.P. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm. Res. 25 (2007) 530-541
9. Remenar J.F., Morissette S.L., Peterson M.L., Moulton B., Macphee J.M., Guzmán H.R., and Almarsson O. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxilic acids. J. Am. Chem. Soc. 125 (2003) 8456-8457
10. McNamara D.P., Childs S.L., Giordano J., Iarriccio A., Cassidy J., Shet M.S., Mannion R., O'Donnell E., and Park A. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm. Res. 23 (2006) 1888-1897
11. Walsh R.D.B., Bradner M.W., Fleischman S., Morales L.A., Moulton B., Rodríguez-Hornedo N., and Zaworotko M.J. Crystal engineering of the composition of pharmaceutical phases. Chem. Commun. (2003) 186-187
12. Friščić T., Trask A.V., Motherwell W.D.S., and Jones W. Guest-directed assembly of caffeine and succinic acid into topologically different heteromolecular host networks upon grinding. Cryst. Growth Des. 8 (2008) 1605-1609
13. Hickey M.B., Peterson M.L., Scoppettuolo L.A., Morrisette S.L., Vetter A., Guzmán H., Remenar J.F., Zhang Z., Tawa M.D., Haley S., Zaworotko M.J., and Almarsson O. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur. J. Pharm. Biopharm. 67 (2007) 112-119
14. Takata N., Shiraki K., Takano R., Hayashi Y., and Terada K. Cocrystal screening of stanolone and mestanolone using slurry crystallization. Cryst. Growth Des. 8 (2008) 3032-3037
15. Desiraju G.R. Crystal and co-crystal. Cryst. Eng. Commun. 5 (2003) 466-467
16. Schultheiss N., and Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst. Growth Des. 9 (2009) 2950-2967
17. Dunitz J.D. Crystal and co-crystal: a second opinion. Cryst. Eng. Commun. 5 (2003) 506-1506
18. Bond A.D. What is a co-crystal?. Cryst. Eng. Commun. 9 (2007) 833-834
19. Zukerman-Schpector J., and Tiekink E.R.T. What is a co-crystal?. Z. Kristallogr. 223 (2008) 233-234
20. Childs S.L., Stahly G.P., and Park A. The salt-cocrystal continuum: the influence of crystal structure on ionization state. Mol. Pharm. 4 (2007) 323-338
21. Aakeröy C.B., Fasulo M.E., and Desper J. Cocrystal or salt: does it really matter?. Mol. Pharm. 4 (2007) 317-322
22. Aakeröy C.B., and Salmon D.J. Building co-crystals with molecular sense and supramolecular sensibility. Cryst. Eng. Commun. 7 (2005) 439-448
23. Trask A.V., and Jones W. Crystal engineering of organic cocrystals by the solid state grinding approach. Top. Curr. Chem. 254 (2005) 41-70
24. ter Horst J.H., and Cains P.W. Co-crystal polymorphs from a solvent-mediated transformation. Cryst. Growth Des. 8 (2008) 2537-2542
25. Morissette S.L., Almarsson O., Peterson M.L., Remenar J.F., Read M.J., Lemmo A.V., Ellis S., Cima M.J., and Gardner C.R. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv. Drug Deliv. Rev. 56 (2004) 275-300
26. Rodríguez-Hornedo N., Nehm S.J., Seefeldt K.F., Págan-Torres Y., and Falkiewicz C.J. Reaction crystallization of pharmaceutical molecular complexes. Mol. Pharm. 3 (2006) 362-367
27. Lu E., Rodríguez-Hornedo N., and Suryanarayanan R. A rapid thermal method for cocrystal screening. Cryst. Eng. Commun. 10 (2008) 665-668
28. Trask A.V., van de Streek J., Motherwell W.D.S., and Jones W. Achieving polymorphic and stoichiometric diversity in cocrystal formation: importance of solid-state grinding, powder X-ray structure determination, and seeding. Cryst. Growth Des. 5 (2005) 2233-2241
29. Weyna D.R., Shattock T., Vishweshwar P., and Zaworotko M.J. Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: mechanochemistry vs slow evaporation from solution. Cryst. Growth Des. 9 (2009) 1106-1123
30. Friščić T., and Jones W. Recent advances in understanding the mechanism of cocrystal formation via grinding. Cryst. Growth Des. 9 (2009) 1621-1637
31. Karki S., Friščić T., and Jones W. Control and interconversion of cocrystal stoichiometry in grinding: stepwise mechanism for the formation of a hydrogen-bonded cocrystal. Cryst. Eng. Commun. 11 (2009) 470-481
32. Braga D., and Grepioni F. Reactions between or within molecular crystals. Angew. Chem. 43 (2004) 4002-4011
33. Trask A.V., Shan N., Motherwell W.D.S., Jones W., Feng S., Tan R.B.H., and Carpenter K.J. Selective polymorph transformation via solvent-drop grinding. Chem. Commun. (2005) 880-882
34. Padrela L., Rodrigues M.A., Velaga S.P., Matos H.A., and Azevedo E.G. Generation of pharmaceutical cocrystals using supercritical fluid technology. Proc. of the 10th Int. Chem. & Biol. Eng. Conference, CHEMPOR 2008. Braga, Portugal (2008)
35. 2. Pharm. Res. 18 (2001) 682-688
36. Moribe K., Tozuka Y., and Yamamoto K. Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation. Adv. Drug Deliv. Rev. 60 (2008) 328-338
37. Shinozaki H., Oguchi T., Suzuki S., Aoki K., Sako T., Morishita S., Tozuka Y., Moribe K., and Yamamoto K. Micronization and polymorphic conversion of tolbutamide and barbital by rapid expansion of supercritical solutions. Drug Dev. Ind. Pharm. 32 (2006) 877-891
38. Martín A., Scholle K., Mattea F., Meterc D., and Cocero M.J. Production of polymorphs of ibuprofen sodium by supercritical antisolvent (SAS) precipitation. Cryst. Growth Des. 9 (2009) 2504-2511
39. Padrela L., Rodrigues M.A., Velaga S.P., Matos H.A., and Azevedo E.G. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. Eur. J. Pharm. Sci. 38 (2009) 9-17
40. Rodrigues M.A., Padrela L., Li J., Almeida A., Matos H.A., and Azevedo E.G. Anti-solvent effect in the production of lysozyme nano- and microparticles by supercritical fluid-assisted atomization processes. J. Supercrit. Fluids 48 (2009) 253-260
41. Lian Z.W., and Lin S.P. Breakup of a liquid jet in a swirling gas. Phys. Fluids A: Fluid Dyn. 2 (1990) 2134-2139
42. Nasr G.G. Industrial Sprays and Atomization: Design, Analysis and Applications (2002), Springer, London
43. Henczka M., Baldyga J., and Shekunov B.Y. Particle formation by turbulent mixing with supercritical antisolvent. Chem. Eng. Sci. 60 (2005) 2193-2201
44. Reverchon E. Supercritical-assisted atomization to produce micro- and/or nanoparticles of controlled size and distribution. Ind. Eng. Res. 41 (2002) 2405-2411
45. Sievers R.E., Quinn B.P., Cape S.P., Searles J.A., Braun C.S., Bhagwat P., Rebits L.G., McAdams D.H., Burger J.L., Best J.A., Lindsay L., Hernandez M.T., Kisich K.O., Iacovangelo T., Kristensen D., and Chen D. Near-critical fluid micronization of stabilized vaccines, antibiotics and anti-virals. J. Supercrit. Fluids 42 (2007) 385-391
46. Porta G.D., Vittori C.D., and Reverchon E. Supercritical assisted atomization: a novel technology for microparticles preparation of an asthma-controlling drug. AAPS Pharm. Sci. Technol. 6 (2005) 421-428
47. Velaga S.P., Berger R., and Carlfors J. Supercritical fluids crystallization of budesonide and flunisolide. Pharm. Res. 19 (2002) 1564-1571
48. Young T.J., Mawson S., Johnston K.P., Hendriksen I.B., Pace G.W., and Mishra A.K. Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs. Biotechnol. Prog. 16 (2000) 402-407
49. Randolph T.W., Randolph A.D., Mebes M., and Yeung S. Sub-micrometer-sized biodegradable particles of poly (l-lactic acid) via the gas antisolvent spray precipitation process. Biotechnol. Prog. 9 (1993) 429-435
50. Jung J., and Perrut M. Particle design using supercritical fluids: literature and patent survey. J. Supercrit. Fluids 20 (2001) 179-219
51. Pasquali I., and Bettini R. Are pharmaceuticals really going supercritical?. Int. J. Pharm. 364 (2008) 176-187
52. Reverchon E., and Spada A. Crystalline microparticles of controlled size produced by supercritical-assisted atomization. Ind. Eng. Chem. Res. 43 (2004) 1460-1465
53. Martín A., and Cocero M.J. Micronization processes with supercritical fluids: fundamentals and mechanisms. Adv. Drug Deliv. Rev. 60 (2008) 339-350
54. Fages J., Lochard H., Letourneau J.-J., Sauceau M., and Rodier E. Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Technol. 141 (2004) 219-226
55. Hakuta Y., Hayashi H., and Arai K. Fine particle formation using supercritical fluids. Curr. Opin. Solid State Mater. Sci. 7 (2003) 341-351
56. Shariati A., and Peters C.J. Recent developments in particle design using supercritical fluids. Curr. Opin. Solid State Mater. Sci. 7 (2003) 371-383
57. Perrut M., Jung J., and Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I. Micronization of neat particles. Int. J. Pharm. 288 (2005) 3-10
58. Kluge J., Fusaro F., Casas N., Mazzotti M., and Muhrer G. Production of PLGA micro- and nanocomposites by supercritical fluid extraction of emulsions. I. Encapsulation of lysozyme. J. Supercrit. Fluids 50 (2009) 327-335
59. Tandya A., Dehghani F., and Foster N.R. Micronization of cyclosporine using dense gas techniques. J. Supercrit. Fluids 37 (2006) 272-278
60. Velaga S.P., Basavoju S., and Böstrom D. Norfloxacin saccharinate-saccharin dihydrate cocrystal-a new pharmaceutical cocrystal with an organic counter ion. J. Mol. Struct. 889 (2008) 150-153
61. Cooke C.L., and Davey R.J. On the solubility of saccharinate salts and cocrystals. Cryst. Growth Des. 8 (2008) 3483-3485
62. Li J., Rodrigues M., Paiva A., Matos H.A., and Gomes de Azevedo E. VLE of carbon dioxide/ethanol/water: applications to volume expansion evaluation and water removal efficiency. Ind. Eng. Chem. Res. 44 (2005) 6751-6759
63. Berry D.J., Seaton C.C., Clegg W., Harrington R.W., Coles S.J., Horton P.N., Hursthouse M.B., Storey R., Jones W., Friscic T., and Blagden N. Applying hot-stage microscopy to co-crystal screening: a study of nicotinamide with seven active pharmaceutical ingredients. Cryst. Growth Des. 8 (2008) 1697-1712